This book gathers international and national reports from across the globe on key questions in the field of antitrust and intellectual property. The first part

Reverse payment settlements or “pay-for-delay agreements” between originators and generic drug manufacturers create heated debates regarding the balance bet

This book provides a systematic analysis of the law and practice of EU competition/antitrust law and trade regulation in the pharmaceutical sector. Authored by

This book further develops both the traditional and the behavioural approach to competition law, and applies these approaches to a variety of timely issues. It